Michael Hoelscher

This paper identifies a potent, broad neutralizing antibody targeting a glycan-independent V3 epitope on HIV-1 Env, showing enhanced neutralization potency and resistance to escape mutations.

The paper identifies a new broadly neutralizing antibody, 04_A06, with high potency and breadth against HIV-1 strains, showing potential for prevention and therapy.

This study evaluates the Molecular Bacterial Load assay (MBLA) for diagnosing and monitoring tuberculosis treatment response, finding it provides reliable, contamination-resistant results faster than traditional methods.